Are hard to treat HCV patients still ‘special’?

Back in the old days of interferon based regimens we had patient groups that were considered ‘special’ because they were hard to treat. But is this still the case? International hepatitis expert Professor Coleman Smith answers the question in an address to the conference on state of the art treatment options in hepatitis C. Speaking ...

Already a member?

Login to keep reading.

© 2021 the limbic